These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21129343)

  • 1. Novopen Echo® for the delivery of insulin: a comparison of usability, functionality and preference among pediatric subjects, their parents, and health care professionals.
    Olsen BS; Lilleøre SK; Korsholm CN; Kracht T
    J Diabetes Sci Technol; 2010 Nov; 4(6):1468-75. PubMed ID: 21129343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the NovoPen® Echo for the delivery of insulin: a comparison of usability, functionality, and preference among pediatric subjects, their parents, and health care professionals.
    Reynholds C; Antal Z
    J Diabetes Sci Technol; 2010 Nov; 4(6):1476-8. PubMed ID: 21129344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a new durable insulin pen with memory function among people with diabetes and healthcare professionals.
    Guo X; Sommavilla B; Vanterpool G; Qvist M; Bethien M; Lilleøre SK
    Expert Opin Drug Deliv; 2012 Apr; 9(4):355-6. PubMed ID: 22432521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of 25 years' experience with the NovoPen family of insulin pens in the management of diabetes mellitus.
    Hyllested-Winge J; Jensen KH; Rex J
    Clin Drug Investig; 2010; 30(10):643-74. PubMed ID: 20701399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, open-label, comparative crossover handling trial between two durable pens in patients with type 1 or 2 diabetes mellitus.
    Sommavilla B; Pietranera G
    J Diabetes Sci Technol; 2011 Sep; 5(5):1212-21. PubMed ID: 22027321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose accuracy of the ClikSTAR, NovoPen 4, and Luxura insulin pens: results of laboratory and field studies.
    Friedrichs A; Basso N; Adler S
    J Diabetes Sci Technol; 2011 Sep; 5(5):1179-84. PubMed ID: 22027314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NovoPen Echo(®) insulin delivery device.
    Hyllested-Winge J; Sparre T; Pedersen LK
    Med Devices (Auckl); 2016; 9():11-8. PubMed ID: 26793007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of preference for NovoPen(®) 4 with previous insulin pen treatments after 12 weeks in adult patients with type 1 and type 2 diabetes: a multicenter observational study.
    Israël-Bultman H; Hyllested-Winge J; Kolaczynski M; Steindorf J; Garon J
    Clin Ther; 2011 Mar; 33(3):346-57. PubMed ID: 21600387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Insulin Underdelivery from Prefilled and Reusable Insulin Pens in Cases of Premature Needle Withdrawal: A Laboratory Evaluation.
    Joubert M; Haddouche A; Morera J; Rod A; Reznik Y
    Diabetes Technol Ther; 2015 Oct; 17(10):712-6. PubMed ID: 26355757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of clinically relevant technical attributes of five insulin injection pens.
    Asakura T
    J Diabetes Sci Technol; 2011 Sep; 5(5):1203-9. PubMed ID: 22027319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient acceptance and issues of education of two durable insulin pen devices.
    Asakura T; Seino H; Jensen KH
    Diabetes Technol Ther; 2008 Aug; 10(4):299-304. PubMed ID: 18715204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of a new reusable insulin pen.
    Penfornis A
    Diabetes Technol Ther; 2011 Mar; 13(3):373-9. PubMed ID: 21291331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Half-Unit Insulin Pens: Disease Management in Patients With Diabetes Who Are Sensitive to Insulin.
    Klonoff DC; Nayberg I; Stauder U; Oualali H; Domenger C
    J Diabetes Sci Technol; 2017 May; 11(3):623-630. PubMed ID: 27898389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatrics, Pens, and Pumps.
    Hieronymus L; Hepner A; Cherolis J
    Diabetes Self Manag; 2015; 32(2):20-3. PubMed ID: 26665831
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparing patient preferences and healthcare provider recommendations with the pen versus vial-and-syringe insulin delivery in patients with type 2 diabetes.
    Ahmann A; Szeinbach SL; Gill J; Traylor L; Garg SK
    Diabetes Technol Ther; 2014 Feb; 16(2):76-83. PubMed ID: 24266497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of preference for a novel durable insulin pen with memory function among patients with diabetes and health care professionals.
    Klausmann G; Hramiak I; Qvist M; Mikkelsen KH; Guo X
    Patient Prefer Adherence; 2013; 7():285-92. PubMed ID: 23630416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No effect of insulin pen with memory function on glycemic control in a patient cohort with poorly controlled type 1 diabetes: a randomized open-label study.
    Danne T; Forst T; Deinhard J; Rose L; Moennig E; Haupt A
    J Diabetes Sci Technol; 2012 Nov; 6(6):1392-7. PubMed ID: 23294785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis and perspective: A randomized, open-label, comparative crossover handling trial between two durable pens in patients with type 1 or 2 diabetes mellitus.
    Bailey TS
    J Diabetes Sci Technol; 2011 Sep; 5(5):1222-3. PubMed ID: 22027322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and patient perception of an insulin pen with simple memory function for children and adolescents with type 1 diabetes--the REMIND study.
    Adolfsson P; Veijola R; Huot C; Hansen HD; Lademann JB; Phillip M
    Curr Med Res Opin; 2012 Sep; 28(9):1455-63. PubMed ID: 22640459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toddlers' diabetes: the lost insulin drop and SemiPens vs. DeciPen.
    Abul-Ainine AA; Abul-Ainine SA
    Pediatr Diabetes; 2014 Jun; 15(4):319-23. PubMed ID: 25584371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.